01 5Belmore Neidrauer LLP
01 52635692
01 5GUSELKUMAB
01 5SOLUTION
01 52026-12-28
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 200 mg / 2 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 200 mg / 2 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA I.V.
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 200 mg / 20 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 100 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA ONE-PRESS
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 100 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
